GH1 and cancer: Nevertheless, the use of GH in cancer survivors and in short children with RASopathies, (caused by germline pathogenic variants in genes that encode RAS pathway proteins, which make affected patients at increased risk of cancer [73]), chromosomal breakage syndromes or DNA-repair disorders should be carefully evaluated owing to an increased risk of recurrence of primary cancer, or second neoplasm in these individuals [72].